Title:
LYMPHOCYTIC ACTIVATION INHIBITOR AND REMEDIAL AGENT FOR AUTOIMMUNE DISEASE
Document Type and Number:
WIPO Patent Application WO/2003/022271
Kind Code:
A1
Abstract:
A lymphocytic activation inhibitor and a remedial agent for autoimmune diseases which each comprises as an active ingredient a sulfonamide derivative or sulfonic ester derivative represented by the general formula (I): (I) [wherein ring A means an optionally substituted, mono− or bicyclic aromatic ring&semi ring B means an optionally substituted, 6−membered, cyclic unsaturated hydrocarbon or an unsaturated 6−membered heterocycle containing one nitrogen atom&semi ring C means an optionally substituted 5−membered heterocycle containing one or two nitrogen atoms&semi W means a single bond or −CH=CH−&semi X means −N(R1)− or oxygen&semi Y means carbon or nitrogen&semi Z means −N(R2)− or nitrogen&semi and R1 and R2 are the same or different and each means hydrogen or lower alkyl], a pharmacologically acceptable salt thereof, or a hydrate of any of these.
Inventors:
HANADA TAKAHISA (JP)
YAMAUCHI TOSHIHIKO (JP)
CHIBA KENICHI (JP)
OWA TAKASHI (JP)
HIDA TAKAYUKI (JP)
MIYAMOTO NORIMASA (JP)
YAMAUCHI TOSHIHIKO (JP)
CHIBA KENICHI (JP)
OWA TAKASHI (JP)
HIDA TAKAYUKI (JP)
MIYAMOTO NORIMASA (JP)
Application Number:
PCT/JP2002/009030
Publication Date:
March 20, 2003
Filing Date:
September 05, 2002
Export Citation:
Assignee:
EISAI C0 LTD (JP)
HANADA TAKAHISA (JP)
YAMAUCHI TOSHIHIKO (JP)
CHIBA KENICHI (JP)
OWA TAKASHI (JP)
HIDA TAKAYUKI (JP)
MIYAMOTO NORIMASA (JP)
HANADA TAKAHISA (JP)
YAMAUCHI TOSHIHIKO (JP)
CHIBA KENICHI (JP)
OWA TAKASHI (JP)
HIDA TAKAYUKI (JP)
MIYAMOTO NORIMASA (JP)
International Classes:
A61K31/404; A61K31/416; A61K31/4178; A61K31/427; A61K31/437; A61K31/4439; A61K45/06; A61P1/00; A61P1/02; A61P3/10; A61P5/50; A61P19/02; A61P19/04; A61P25/00; A61P27/02; A61P29/00; A61P37/00; A61P37/02; (IPC1-7): A61K31/404; A61K31/416; A61K31/4178; A61K31/427; A61K31/437; A61K31/4439; A61K45/00; A61P1/00; A61P1/02; A61P3/10; A61P5/50; A61P19/02; A61P19/04; A61P25/00; A61P27/02; A61P29/00; A61P37/00; A61P37/02; C07D209/30; C07D209/34; C07D209/42; C07D231/56; C07D401/12; C07D403/12; C07D405/12; C07D409/14; C07D417/12; C07D471/04
Domestic Patent References:
WO2001056607A1 | 2001-08-09 | |||
WO2001053266A1 | 2001-07-26 | |||
WO2000050395A1 | 2000-08-31 | |||
WO1999018076A1 | 1999-04-15 | |||
WO1997048368A2 | 1997-12-24 |
Foreign References:
JP2002167376A | 2002-06-11 | |||
JP2000309534A | 2000-11-07 | |||
US5939431A | 1999-08-17 | |||
JPS5589222A | 1980-07-05 |
Other References:
See also references of EP 1430894A4
Attorney, Agent or Firm:
Toyama, Tsutomu (4-10 Higashi Nihonbashi 3-chom, Chuo-ku Tokyo, JP)
Download PDF:
Previous Patent: TRANSDERMAL ADMINISTRATION OF AN ENALAPRIL ESTER
Next Patent: 2-AROYLIMIDAZOLE COMPOUNDS FOR TREATING CANCER
Next Patent: 2-AROYLIMIDAZOLE COMPOUNDS FOR TREATING CANCER